Analyst firms · Cantor Fitzgerald · REPL
Cantor Fitzgerald REPL price target and rating history
Replimune Group Inc. (REPL) · Health Care
Cantor Fitzgerald rates Replimune Group Inc. (REPL) Overweight, as of its latest action on Jul 31, 2026. It has published 3 rating actions on REPL since June 2025, including 2 upgrades and 0 downgrades. Across 5 firms with a REPL price target in the last 12 months, the median target is $12.
- Current rating
- Overweight
- Price target
- Not stated
- Median target, all firms
- $12
- Actions on REPL
- 3
Every Cantor Fitzgerald rating on REPL
- Jul 31, 2026
- Jul 30, 2025
- Jun 20, 2025
How other firms rate REPL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wedbush | Outperform | $12 | Aug 7, 2026 |
| Leerink Partners | Outperform | $17 | Aug 4, 2026 |
| Cantor Fitzgerald | Overweight | Jul 31, 2026 | |
| BMO Capital Markets | Outperform | $16 | Jun 30, 2026 |
| Jefferies | Hold | $2 | Apr 13, 2026 |
| H.C. Wainwright | Sell | Apr 13, 2026 | |
| Piper Sandler | Neutral | $4 | Apr 10, 2026 |
Questions about Cantor Fitzgerald and REPL
- What is Cantor Fitzgerald's rating on REPL?
- Cantor Fitzgerald rates REPL Overweight, a bullish rating, as of Jul 31, 2026.
- When did Cantor Fitzgerald last change its view on REPL?
- On Jul 31, 2026, Cantor Fitzgerald upgrades to Overweight from Neutral.
- How does Cantor Fitzgerald's REPL target compare with other analysts?
- Across 5 firms with a REPL price target in the last 12 months, the median target is $12.
More REPL rating histories
All Cantor Fitzgerald ratingsREPL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.